DZ Bank Upgrades Danaher (NYSE:DHR) to Strong-Buy

Danaher (NYSE:DHR) was upgraded by equities researchers at DZ Bank to a “strong-buy” rating in a research note issued on Tuesday,Zacks.com reports.

Several other equities research analysts also recently issued reports on DHR. Citigroup initiated coverage on shares of Danaher in a research note on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price objective on the stock. Jefferies Financial Group restated a “buy” rating and issued a $245.00 price objective on shares of Danaher in a research note on Tuesday, April 21st. UBS Group lowered their price objective on shares of Danaher from $270.00 to $250.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. Wolfe Research downgraded shares of Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday. Finally, Evercore raised their price objective on shares of Danaher from $225.00 to $232.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 21st. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $235.14.

Danaher Trading Up 1.3%

Shares of Danaher stock opened at $178.40 on Tuesday. The company’s fifty day simple moving average is $181.40 and its 200-day simple moving average is $206.59. The company has a market cap of $126.26 billion, a price-to-earnings ratio of 34.51, a PEG ratio of 2.35 and a beta of 0.81. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. Danaher has a 1 year low of $160.93 and a 1 year high of $242.80.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.94 by $0.12. The business had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. Danaher’s quarterly revenue was up 3.7% on a year-over-year basis. During the same quarter last year, the company posted $1.88 earnings per share. As a group, sell-side analysts expect that Danaher will post 8.43 EPS for the current year.

Institutional Trading of Danaher

A number of hedge funds and other institutional investors have recently made changes to their positions in DHR. Main Street Group LTD acquired a new stake in shares of Danaher in the first quarter valued at $25,000. JPL Wealth Management LLC acquired a new stake in shares of Danaher in the third quarter valued at $25,000. Elevated Capital Advisors LLC acquired a new stake in shares of Danaher in the fourth quarter valued at $26,000. WFA of San Diego LLC acquired a new stake in shares of Danaher in the second quarter valued at $26,000. Finally, ANTIPODES PARTNERS Ltd acquired a new stake in shares of Danaher in the third quarter valued at $27,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.